| |
Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 46, No. 7. (July 2005), pp. 774-803.
|
| |
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 370-374.
Abstract
Attention deficit hyperactivity disorder (ADHD) is a common neuropsychiatric condition with strong genetic basis. Recent work in China indicated that ADHD may be linked to Xp1-2 in the Han Chinese population. The gene encoding monoamine oxidase B (MAOB), the main enzyme degrading dopamine in the human brain, is located in this region. The current study sequenced the exons and the 5' and 3' flanking regions of the MAOB gene and found four common variants including 2276C>T and 2327C>T in exon 15, ...
|
| |
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 316-319.
by E. J. S. Sonuga-Barke, K. J. Brookes, J. Buitelaar, et al.R. Anney, P. Bitsakou, D. Baeyens, C. Buschgens, W. Chen, H. Christiansen, J. Eisenberg, J. Kuntsi, I. Manor, A. Meliá, A. Mulligan, N. Rommelse, U. C. Müller, H. Uebel, T. Banaschewski, R. Ebstein, B. Franke, M. Gill, A. Miranda, R. D. Oades, H. Roeyers, A. Rothenberger, J. Sergeant, H. C. Steinhausen, M. Thompson, E. Taylor, P. Asherson, S. V. Faraone
Abstract
A major goal of genetic studies of attention deficit hyperactivity disorder (ADHD) is to identify individual characteristics that might help segregate the disorder's inherent heterogeneity. [Mill et al. (2006); Arch Ger Psychiatry 63:462-469] recently reported a potentially important association between two dopamine-related risk polymorphisms (DRD4 variable number tandem repeat (VNTR) in exon 3 and DAT1 VNTR in the 3 UTR) and lowered IQ in ADHD. The objective of the current study was to replicate the [Mill et al. (2006); Arch Ger ...
|
| |
World psychiatry : official journal of the World Psychiatric Association (WPA), Vol. 2, No. 2. (June 2003), pp. 104-113.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a behavioral disorder that affects up to 1 in 20 children in the USA. The predominance of American research into this disorder over the past 40 years has led to the impression that ADHD is largely an American disorder and is much less prevalent elsewhere. This impression was reinforced by the perception that ADHD may stem from social and cultural factors that are most common in American society. However, another school of thought suggested that ADHD is ...
|
| |
Medscape General Medicine, Vol. 8, No. 4. (2006)
Abstract
OBJECTIVE: Medications used to treat attention-deficit/hyperactivity disorder (ADHD) have been well researched, but comparisons among drugs are hindered by the absence of direct comparative trials. METHODS: We analyzed recent published literature on the pharmacotherapy of ADHD to describe the variability of drug-placebo effect sizes. A literature search was conducted to identify double-blind, placebo-controlled studies of ADHD youth published after 1979. Meta-analysis regression assessed the influence of medication type and study design features on medication effects. RESULTS: Twenty-nine trials met criteria and ...
|
| |
American Journal of Psychiatry, Vol. 150, No. 12. (1 December 1993), pp. 1792-1798.
|
| |
American Journal of Psychiatry, Vol. 153, No. 9. (1 September 1996), pp. 1138-1142.
|
| |
American Journal of Psychiatry, Vol. 153, No. 9. (1 September 1996), pp. 1147-1153.
|
| |
Focus, Vol. 1, No. 2. (1 April 2003), pp. 196-204.
Abstract
Objective. To evaluate whether attention-deficit hyperactivity disorder (ADHD) is a risk factor for psychoactive substance use disorders (PSUD), attending to issues of psychiatric comorbidity, family history, and adversity. Method. Using assessments from multiple domains, the authors examined 140 ADHD and 120 normal control subjects at baseline and 4 years later. Drug and alcohol abuse and dependence were operationally defined. Results. No differences were detected in the rates of alcohol or drug abuse or dependence or in the rates of abuse of ...
|
| |
American Journal of Psychiatry, Vol. 152, No. 11. (1 November 1995), pp. 1652-1658.
|
| |
American Journal of Psychiatry, Vol. 165, No. 1. (1 January 2008), pp. 107-115.
Abstract
OBJECTIVE: A robust and bidirectional comorbidity between attention deficit hyperactivity disorder (ADHD) and psychoactive substance use disorder (alcohol or drug abuse or dependence) has been consistently reported in the extant literature. METHOD: First-degree relatives from a large group of pediatrically and psychiatrically referred boys with (112 probands, 385 relatives) and without (105 probands, 358 relatives) ADHD were comprehensively assessed by blind raters with structured diagnostic interviews. Familial risk analysis examined the risks in first-degree relatives for ADHD, psychoactive substance use disorder, ...
|
| |
Archives of Pediatrics & Adolescent Medicine, Vol. 152, No. 10. (October 1998), pp. 945-951.
Abstract
OBJECTIVE: To test hypotheses about patterns of familial association between attention-deficit/hyperactivity disorder (ADHD) and psychoactive substance use disorders (PSUDs) by using the family study method. DESIGN: The first-degree relatives of clinically referred children and adolescents with ADHD (131 probands, 413 relatives) and healthy control probands (106 probands, 323 relatives) were assessed by blind raters. RESULTS: After stratifying the probands with ADHD and the control probands into those with PSUD (group 1 and group 3, respectively) and those without PSUD (group 2 ...
|
| |
Pediatrics, Vol. 104, No. 2. (1 August 1999), e20.
Abstract
OBJECTIVE: To assess the risk for substance use disorders (SUD) associated with previous exposure to psychotropic medication in a longitudinal study of boys with attention-deficit/hyperactivity disorder (ADHD). METHODS: The cumulative incidence of SUD throughout adolescence was compared in 56 medicated subjects with ADHD, 19 nonmedicated subjects with ADHD, and 137 non-ADHD control subjects. RESULTS: Unmedicated subjects with ADHD were at a significantly increased risk for any SUD at follow-up compared with non-ADHD control subjects (adjusted OR: 6.3 [1.8-21.6]). Subjects with ADHD ...
|
| |
JAMA, Vol. 292, No. 5. (August 2004), pp. 619-623.
|
| |
Archives of Internal Medicine, Vol. 164, No. 11. (June 2004), pp. 1221-1226.
Abstract
Background Recognition and treatment of attention-deficit/hyperactivity disorder (ADHD) in adults in psychiatry and primary care have faced many obstacles. Methods Review by 50 psychiatrists and 50 primary care practitioners (PCPs) of 537 and 317 medical records, respectively, of adults diagnosed as having ADHD. Information on other psychiatric disorders, time of onset of ADHD, source of referral, use of referrals for diagnosis, ADHD treatment, and use of drug holidays was recorded. Results Forty-five percent of the patient records reviewed by psychiatrists and ...
|
| |
American Journal of Psychiatry, Vol. 163, No. 4. (1 April 2006), pp. 716-723.
by R. C. Kessler, L. Adler, R. Barkley, et al.J. Biederman, C. K. Conners, O. Demler, S. V. Faraone, L. L. Greenhill, M. J. Howes, K. Secnik, T. Spencer, T. B. Ustun, E. E. Walters, A. M. Zaslavsky
Abstract
OBJECTIVE: Despite growing interest in adult attention deficit hyperactivity disorder (ADHD), little is known about its prevalence or correlates. METHOD: A screen for adult ADHD was included in a probability subsample (N=3,199) of 18-44-year-old respondents in the National Comorbidity Survey Replication, a nationally representative household survey that used a lay-administered diagnostic interview to assess a wide range of DSM-IV disorders. Blinded clinical follow-up interviews of adult ADHD were carried out with 154 respondents, oversampling those with positive screen results. Multiple imputation ...
|
| |
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 1. (2008), pp. 94-99.
by K. J. Brookes, B. Neale, X. Xu, et al.A. Thapar, M. Gill, K. Langley, Z. Hawi, J. Mill, E. Taylor, B. Franke, W. Chen, R. Ebstein, J. Buitelaar, T. Banaschewski, E. Sonuga-Barke, J. Eisenberg, Manor, A. Miranda, R. D. Oades, H. Roeyers, A. Rothenberger, J. Sergeant, H. C. Steinhausen, S. V. Faraone, P. Asherson
Abstract
Season of birth (SOB) has been associated with attention deficit hyperactivity disorder (ADHD) in two existing studies. One further study reported an interaction between SOB and genotypes of the dopamine D4 receptor (DRD4) gene. It is important that these findings are further investigated to confirm or refute the findings. In this study, we investigated the SOB association with ADHD in four independent samples collected for molecular genetic studies of ADHD and found a small but significant increase in summer births compared ...
|
| |
Biological Psychiatry, Vol. 60, No. 10. (15 November 2006), pp. 1081-1087.
Abstract
Background Diagnosing attention-deficit/hyperactivity disorder (ADHD) in adults is difficult when the diagnostician cannot establish an onset prior to the DSM-IV criterion of age 7 or if the number of symptoms recalled does not achieve the DSM-IV threshold for diagnosis. Because neuropsychological deficits are associated with ADHD, we addressed the validity of the DSM-IV age at onset and symptom threshold criteria by using neuropsychological test scores as external validators.Methods We compared four groups of adults: 1) full ADHD subjects met all DSM-IV ...
|
| |
Cerebral Cortex (18 August 2006)
Abstract
Attention-deficit/hyperactivity disorder (ADHD) has been associated with structural alterations in brain networks influencing cognitive and motor behaviors. Volumetric studies in children identify abnormalities in cortical, striatal, callosal, and cerebellar regions. In a prior volumetric study, we found that ADHD adults had significantly smaller overall cortical gray matter, prefrontal, and anterior cingulate volumes than matched controls. Thickness and surface area are additional indicators of integrity of cytoarchitecture in the cortex. To expand upon our earlier results and further refine the regions of ...
|
| |
Biol Psychiatry, Vol. 60, No. 10. (15 November 2006), pp. 1071-1080.
by L. J. Seidman, E. M. Valera, N. Makris, et al.M. C. Monuteaux, D. L. Boriel, K. Kelkar, D. N. Kennedy, V. S. Caviness, G. Bush, M. Aleardi, S. V. Faraone, J. Biederman
Abstract
OBJECTIVES: Gray and white matter volume deficits have been reported in a number of studies of children with attention-deficit/hyperactivity disorder (ADHD); however, there is a paucity of structural magnetic resonance imaging (MRI) studies of adults with ADHD. This structural MRI study used an a priori region of interest approach. METHODS: Twenty-four adults with DSM-IV ADHD and 18 healthy controls comparable on age, socioeconomic status, sex, handedness, education, IQ, and achievement test performance had an MRI on a 1.5T Siemens scanner. Cortical ...
|
| |
Journal of Attention Disorders, Vol. 9, No. 2. (1 November 2005), pp. 384-391.
Abstract
To provide a better estimate of the prevalence of ADHD in adulthood, the authors complete a telephone survey of 966 randomly selected adults. They compute two diagnoses from the survey data. Participants meeting Diagnostic and Statistical Manual of Mental Disorders (4th ed.) criteria for both childhood and adulthood are defined as narrow ADHD. Broad ADHD adds to that definition those meeting subthreshold criteria. Cronbach's alpha is .90 for the 18 DSM-IV symptoms in childhood and .88 when rated for current symptoms ...
|
| |
American Journal of Psychiatry, Vol. 163, No. 10. (1 October 2006), pp. 1720-1729.
Abstract
OBJECTIVE: Diagnosing attention deficit hyperactivity disorder (ADHD) in adults is difficult when diagnosticians cannot establish an onset before the DSM-IV criterion of age 7 or if the number of symptoms recalled does not achieve DSM's diagnosis threshold. METHOD: The authors addressed the validity of DSM-IV's age-at-onset and symptom threshold criteria by comparing four groups of adults: 127 subjects with full ADHD who met all DSM-IV criteria for childhood-onset ADHD, 79 subjects with late-onset ADHD who met all criteria except the age-at-onset ...
|
| |
American Journal of Psychiatry, Vol. 157, No. 5. (1 May 2000), pp. 816-818.
Abstract
OBJECTIVE: Symptom decline in attention deficit hyperactivity disorder (ADHD) was examined with different definitions of remission.METHOD: Symptoms in 128 boys were measured five times over 4 years. The prevalences of syndromatic (less than full syndrome), symptomatic (less than subthreshold diagnosis), and functional (full recovery) remission were estimated as a function of age with multivariate logistic regression.RESULTS: Age was significantly associated with decline in total ADHD symptoms and symptoms of hyperactivity, impulsivity, and inattention. Symptoms of inattention remitted for fewer subjects than ...
|
| |
Pediatrics, Vol. 111, No. 1. (1 January 2003), pp. 179-185.
Abstract
Objective.Concerns exist that stimulant therapy of youths with attention-deficit/hyperactivity disorder (ADHD) may result in an increased risk for subsequent substance use disorders (SUD). We investigated all long-term studies in which pharmacologically treated and untreated youths with ADHD were examined for later SUD outcomes. Methods.A search of all available prospective and retrospective studies of children, adolescents, and adults with ADHD that had information relating childhood exposure to stimulant therapy and later SUD outcome in adolescence or adulthood was conducted through PubMed supplemented ...
Note (first note only)
URL free
|
| |
Biological Psychiatry, Vol. 57, No. 5. (1 March 2005), pp. 456-463.
Abstract
BackgroundThe few controlled studies of methylphenidate (MPH) in adults with attention deficit/hyperactivity disorder (ADHD) have reported equivocal results. A previous, pilot study by our group suggested that these results were due to inadequate dosing.MethodWe conducted a randomized, 6-week, placebo-controlled, parallel study of MPH in 146 adult patients with DSM-IV ADHD using standardized instruments for diagnosis, separate assessments of ADHD, depressive and anxiety symptoms, and a robust average oral daily dose of 1.1 mg/kg/day.ResultsWe found a marked therapeutic response for the MPH ...
|
| |
Biological Psychiatry, Vol. 55, No. 7. (1 April 2004), pp. 692-700.
Abstract
Background This study reexamined gender differences in a large sample of adults with attention-deficit/hyperactivity disorder (ADHD).Methods We assessed the effects of ADHD, gender, and their interaction on rates of psychiatric comorbidity and cognitive functioning in 219 adults with ADHD who were referred to an outpatient psychiatric clinic over the last 7 years compared with 215 control subjects group-matched to control subjects on age and gender, and ascertained from ongoing family genetic case control adults with ADHD.Results There was no evidence that ...
|